Clin2
NCT06790342Possibly a fitNot yet recruiting

Quitting smoking and reducing alcohol for people with HIV

HIVTobacco UseAlcohol Use Disorder

Part of Mental health clinical trials.

This study tests a combination of counseling and medication to help people with HIV stop smoking and cut down on heavy drinking. It aims to improve overall health and quality of life.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
300 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have HIV.
  • You have smoked a cigarette in the last 7 days.
  • You are motivated to quit smoking within the next 6 months.
  • You drink heavily (4 or more drinks on any day or more than 7 drinks per week).
  • You are willing to take part in counseling and possibly take medication to help with quitting.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05413122Recruiting· Phase 2/Phase 3
Smoking quit support for adults living with HIV in South Africa

This trial tests smoking-cessation interventions to help people living with HIV quit smoking or smoke less. You may be eligible if you smoke, are actively engaged in HIV treatment, and can follow the study for about a year.

Soweto, Gauteng
NCT07835555Not yet recruiting· Phase 4
Stop-smoking help with rewards for people with HIV

This study tests a program that helps people with HIV quit smoking by combining medication, counseling, and financial rewards. It aims to see if this approach works well in HIV clinics and helps reduce smoking.

Bridgeport, Connecticut
NCT06789692Recruiting
Reducing tobacco use in people with HIV

This study combines a medication to help people stop smoking with a custom mobile app, all within the Swiss HIV Cohort Study. It's designed for people living with HIV who smoke and want to quit.

Basel, Basel
NCT05694637Enrolling by invitation· Phase 4
Support to help daily smokers with HIV stay abstinent

This Phase 4 study tests a smoking-quit support approach (reinforcement and coaching) to help people with HIV stop smoking and stay smoke-free. It may help improve smoking abstinence while you continue HIV care.

Francistown, Central District
NCT04725617Recruiting
Smoking-quit program for people with HIV and sleep issues

This study tests a wellness-based smoking-cessation program (including the stop-smoking medicine varenicline) for people living with HIV who want to quit. It aims to help you reduce or stop smoking while monitoring safety, sleep, and mental health during the program.

Phoenix, Arizona
NCT05642715Recruiting
HIV smoking reduction program with varenicline and online support

This study tests a harm-reduction approach to help people with HIV smoke fewer cigarettes and quit if they want, using an online tobacco program and varenicline (a quit-smoking medicine). You may be placed in one of two different study groups to compare how well the approaches work.

The Bronx, New York

Hear when a new HIV trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.